Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
November 08, 2022 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
October 31, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
October 12, 2022 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present its spine procedural...
Bioventus to Present at the Morgan Stanley Global Healthcare Conference
August 30, 2022 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice-president and chief...
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
August 11, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Receives FDA 510(k) Clearance for SonaStar Elite
August 03, 2022 07:00 ET
|
Bioventus, Inc.
Innovative New Handpiece Addition to the Nexus Ultrasonic Generator Significantly Expands Company’s Offering in Neurosurgery Ablation Procedures DURHAM, N.C., Aug. 03, 2022 (GLOBE NEWSWIRE) --...
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
July 26, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Completes CartiHeal Acquisition
July 12, 2022 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has completed...
Bioventus Amends CartiHeal Acquisition Structure
June 21, 2022 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered...
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
May 10, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...